Prostate Cancer
Outcomes of initially expectantly managed patients with low or intermediate risk screen-detected localized prostate cancer - Abstract
September 20, 2012
Factors associated with satisfaction with prostate cancer care: Results from Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE) - Abstract
September 20, 2012
Single application of high-intensity focused ultrasound as a first-line therapy for clinically localized prostate cancer: 5-Year outcomes - Abstract
September 20, 2012
Phase II trial of RAD001 and bicalutamide for castration-resistant prostate cancer - Abstract
September 20, 2012
Associations between intake of folate, methionine, and vitamins B-12, B-6 and prostate cancer risk in American veterans - Abstract
September 20, 2012
High-intensity focused ultrasound for prostate cancer: Long-term followup and complications rate - Abstract
September 20, 2012
Randomized phase II study of danusertib in patients with metastatic castration-resistant prostate cancer after docetaxel failure - Abstract
September 20, 2012
Aspirin use and the risk of prostate cancer mortality in men treated with prostatectomy or radiotherapy - Abstract
September 19, 2012
Associations of circulating retinol, vitamin E, and 1,25-dihydroxyvitamin D with prostate cancer diagnosis, stage, and grade - Abstract
September 19, 2012
Early infectious complications with transponder placement for external beam radiation therapy for prostate cancer - Abstract
September 19, 2012
Role of high dose rate brachytherapy in the treatment of prostate cancer - Abstract
September 19, 2012
Tamoxifen for the management of breast events induced by non-steroidal antiandrogens in patients with prostate cancer: A systematic review - Abstract
September 19, 2012
Impact of body mass index on perioperative morbidity, oncological, and functional outcomes after extraperitoneal laparoscopic radical prostatectomy - Abstract
September 19, 2012
The evolving role of immunotherapy in prostate cancer - Abstract
September 19, 2012
Researchers reveal underlying mechanism of powerful chemotherapy for prostate cancer treatment
September 18, 2012